Herbal Supplements for Improvement of Liver Function in Participants With Alcoholic Liver Disease
NCT03503708 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2018-04-20
Summary
Alcoholic liver disease represents the major health issues and it ranges from simple steatosis to cirrhosis. There is a paucity of data to support the allopathic intervention among these group of patients. Livitol-17 consist of the 3 whole herbs and extract which has antioxidant, hepatoprotective as well as reno-protective properties. The aim of this trial is to study the efficacy of herbal supplement to improve the liver function of alcoholic liver disease subject.
Conditions
Interventions
- DRUG
-
Livitol-70
Livitol-17 detoxifies, purifies and rejuvenates liver, kidney and spleen. Participants will be given the intervention in two bottles at each visit. Participant will be instructed to take two capsule twice daily at a fixed time in the day.
Sponsors & Collaborators
-
Composite Interceptive Med Science
lead INDUSTRY
Principal Investigators
-
Alben Sigamani, MD · Narayana Hrudayalaya Hospital
-
Sanjaya Chauhan, PharmD · Composite Interceptive Med Science
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-05-30
- Primary Completion
- 2018-10-30
- Completion
- 2028-11-30
Countries
- India
Study Locations
More Related Trials
-
Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis
NCT01591200 ·Status: COMPLETED ·Phase: PHASE2
-
Benefit of a Hospital Intervention in Patients With Hepatic Steatosis
NCT06394206 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Pentoxyphilline Versus Fecal Microbiota Therapy in Severe Alcoholic Hepatitis
NCT02458079 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF
NCT01937130 ·Status: TERMINATED ·Phase: PHASE2
-
Ketotifen in Non-Alcoholic Fatty Liver Disease Patients
NCT05616442 ·Status: COMPLETED ·Phase: PHASE4
-
2-Week Study In People With Nonalcoholic Fatty Liver Disease
NCT03513588 ·Status: COMPLETED ·Phase: PHASE1
-
Investigation of Synbiotic Treatment in NAFLD
NCT01680640 ·Status: COMPLETED ·Phase: NA
-
Effect of Bempedoic Acid on Liver Fat in Individuals With Nonalcoholic Fatty Liver Disease and Type 2 Diabetes
NCT06035874 ·Status: RECRUITING ·Phase: NA
-
Development of a Novel Asian Mediterranean Diet and Its Acceptability in NAFLD
NCT06321211 ·Status: COMPLETED
-
A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)
NCT06836609 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Aspirin for the Treatment of Nonalcoholic Fatty Liver Disease
NCT04031729 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Treatment of Nonalcoholic Fatty Liver Disease With Probiotics and Prebiotics
NCT00870012 ·Status: COMPLETED ·Phase: NA
-
The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease
NCT05364684 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Lockdown During COVID 19 Pandemic on Liver Disease and Metabolic Parameters.
NCT05028842 ·Status: COMPLETED
-
Efficacy of Monotherapy vs Combination Therapy of Corticosteroids With GCSF in Severe Alcoholic Hepatitis Patients.
NCT04066179 ·Status: UNKNOWN ·Phase: NA
-
Study of Aramchol in Patients With Fatty Liver Disease or Nonalcoholic Steatohepatitis
NCT01094158 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Alternate Day Fasting Over Standard Medical Management Alone to Reverse Non-alcoholic Steatohepatitis.
NCT06676813 ·Status: RECRUITING ·Phase: NA
-
Fecal Microbiota Therapy in Steroid Ineligible Alcoholic Hepatitis
NCT05285592 ·Status: UNKNOWN ·Phase: NA
-
Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver
NCT02273362 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Indo-Mediterranean Diet on Hepatic Steatosis and Fibrosis in NAFLD Children
NCT05073588 ·Status: COMPLETED ·Phase: NA
-
A Clinical Trial to Evaluate the Efficacy and Safety of MXP22 on Liver Health
NCT05808049 ·Status: COMPLETED ·Phase: NA
-
A Clinical Trial of Longqi Jiangzhi Decoction Against Non-alcoholic Fatty Liver Disease
NCT07320456 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study of IDN-6556 in Subjects With Liver Cirrhosis
NCT02230670 ·Status: COMPLETED ·Phase: PHASE2
-
Hyperbaric Oxygen Therapy for Metabolic Dysfunction-associated Steatotic Liver Diseases
NCT06619808 ·Status: RECRUITING ·Phase: NA
-
Evaluate the Efficacy and Safety of LivPhcD Capsules in the NAFLD Subjects
NCT05930093 ·Status: RECRUITING ·Phase: NA